Literature DB >> 16099320

Gene identification by cDNA arrays in HPV-positive cervical cancer.

Guelaguetza Vázquez-Ortíz1, Carlos J Ciudad, Patricia Piña, Karla Vazquez, Alfredo Hidalgo, Brenda Alatorre, Jose A Garcia, Fabio Salamanca, Raul Peralta-Rodriguez, Angélica Rangel, Mauricio Salcedo.   

Abstract

BACKGROUND: One of the most frequent malignancies in women worldwide is carcinoma of the uterine cervix. High-risk human papillomavirus (HPV) infection is considered the most important etiological factor of uterine cervical cancer. Our aim was to identify novel cellular genes that could potentially act as predictive molecular markers for human cervical cancer by means of cDNA arrays.
METHODS: We used cDNA arrays to examine the expression profiles of six cell lines derived from human cervical cancer, three HPV+ tumor samples and three normal (HPV-) epithelium tissues. Data normalization was performed and the top overexpressed genes were obtained. Hierarchical cluster was performed and, to validate some of the differentially expressed genes between normal and carcinogenic samples, semi-quantitative RT-PCR, in situ hybridization and immunohistochemistry were performed in tissue samples.
RESULTS: Four genes were demonstrated to be consistently overexpressed in invasive cervical cancer biopsies; three novel genes not previously related to cervical cancer: MMP10, Lamc2 and Claudin 1. Moreover, overexpression of IL6 and VEGF was corroborated.
CONCLUSIONS: The identification of characteristic molecular changes in cervical cells by carcinogenesis and HPV infection can lead to a better understanding of cervical cancer. cDNA arrays are beginning to provide new possible molecular markers for prognosis and diagnosis. This technology could eventually help to elucidate the biological differences of the particular mechanisms associated with each different HPV-type infection and those with a poor prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 16099320     DOI: 10.1016/j.arcmed.2005.04.016

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  9 in total

1.  Claudin-1 as a Biomarker of Cervical Cytology and Histology.

Authors:  Márta Benczik; Ádám Galamb; Róbert Koiss; Attila Kovács; Balázs Járay; Tamás Székely; Tímea Szekerczés; Zsuzsa Schaff; Gábor Sobel; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-01       Impact factor: 3.201

2.  HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

Authors:  Shu-Jie Liao; Dong-Rui Deng; Dan Zeng; Ling Zhang; Xiao-Ji Hu; Wei-Na Zhang; Li Li; Xue-Feng Jiang; Chang-Yu Wang; Jian-Feng Zhou; Shi-Xuan Wang; Han-Wang Zhang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

3.  Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.

Authors:  Ting-Yan Shi; Mei-Ling Zhu; Jing He; Meng-Yun Wang; Qiao-Xin Li; Xiao-Yan Zhou; Meng-Hong Sun; Zhi-Ming Shao; Ke-Da Yu; Xi Cheng; Xiaohua Wu; Qingyi Wei
Journal:  Hum Genet       Date:  2012-11-20       Impact factor: 4.132

4.  Molecular profiling of cervical cancer progression.

Authors:  T Hagemann; T Bozanovic; S Hooper; A Ljubic; V I F Slettenaar; J L Wilson; N Singh; S A Gayther; J H Shepherd; P O A Van Trappen
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

5.  Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours.

Authors:  Agnieszka Szala; Sambor Sawicki; Anna St Swierzko; Janusz Szemraj; Marcin Sniadecki; Mateusz Michalski; Andrzej Kaluzynski; Jolanta Lukasiewicz; Anna Maciejewska; Dariusz Wydra; David C Kilpatrick; Misao Matsushita; Maciej Cedzynski
Journal:  Cancer Immunol Immunother       Date:  2013-06-07       Impact factor: 6.968

6.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

7.  Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.

Authors:  Ge Zhang; Makito Miyake; Adrienne Lawton; Steve Goodison; Charles J Rosser
Journal:  BMC Cancer       Date:  2014-05-03       Impact factor: 4.430

8.  Krüppel-Like Factor 10 participates in cervical cancer immunoediting through transcriptional regulation of Pregnancy-Specific Beta-1 Glycoproteins.

Authors:  Daniel Marrero-Rodríguez; Keiko Taniguchi-Ponciano; Malayannan Subramaniam; John R Hawse; Kevin S Pitel; Hugo Arreola-De la Cruz; Victor Huerta-Padilla; Gustavo Ponce-Navarrete; Ma Del Pilar Figueroa-Corona; Laura Gomez-Virgilio; Teresa I Martinez-Cuevas; Monica Mendoza-Rodriguez; Miriam Rodriguez-Esquivel; Pablo Romero-Morelos; Jorge Ramirez-Salcedo; Michael Baudis; Marco Meraz-Rios; Florinda Jimenez-Vega; Mauricio Salcedo
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

Review 9.  Components of the Lectin Pathway of Complement in Solid Tumour Cancers.

Authors:  Maciej Cedzyński; Anna S Świerzko
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.